Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypersensitivity Reaction

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 206 articles:
HTML format



Single Articles


    January 2024
  1. TACHDJIAN R, Savic S, Fridman M, Frade JP, et al
    Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks.
    Allergy Asthma Proc. 2024;45:37-43.
    PubMed     Abstract available


  2. BELLANTI JA, Settipane RA
    Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.
    Allergy Asthma Proc. 2024;45:1-4.
    PubMed    


  3. LUMRY WR, Bernstein JA, Li HH, Levy DS, et al
    An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
    Allergy Asthma Proc. 2024;45:44-49.
    PubMed     Abstract available


  4. LIM PPC, Moore LN, Minich NM, Wessell KR, et al
    Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Allergy Asthma Proc. 2024;45:61-69.
    PubMed     Abstract available


  5. LUNDBERG M, Maurer R, Tchekmedyian R, Mullur J, et al
    Validation of a questionnaire assessing smell loss in an international aspirin-exacerbated respiratory disease population.
    Allergy Asthma Proc. 2024;45:5-13.
    PubMed     Abstract available


  6. CHEN X, Luo H, Yan W, Tang K, et al
    Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort.
    Allergy Asthma Proc. 2024;45:e14-e22.
    PubMed     Abstract available


  7. SHIM JS, Kim MH, Cho YJ
    Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data.
    Allergy Asthma Proc. 2024;45:e1-e8.
    PubMed     Abstract available


  8. BOURGOYNE K, Sampognaro L, Bhat A, Valdes Camacho J, et al
    Health disparities in hymenoptera venom allergy management.
    Allergy Asthma Proc. 2024;45:50-52.
    PubMed     Abstract available


  9. NELSON HS, Bernstein DI, Biedermann T, Nolte H, et al
    Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.
    Allergy Asthma Proc. 2024;45:33-36.
    PubMed     Abstract available


  10. REBROVA S, Emelyanov A, Sergeeva G, Korneenkov A, et al
    Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis.
    Allergy Asthma Proc. 2024;45:e9-e13.
    PubMed     Abstract available



  11. Abstracts presented at the Eastern Allergy Conference June 1-4, 2023, Palm Beach, Florida.
    Allergy Asthma Proc. 2024;45:75-78.
    PubMed    


  12. HODGES M, Freigeh GE, Troost J, Baptist AP, et al
    Assessment of mask use on oxygen saturation in adults and children with asthma.
    Allergy Asthma Proc. 2024;45:24-32.
    PubMed     Abstract available


  13. ARIKOGLU T, Tokmeci N, Demirhan A, Kont Ozhan A, et al
    Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup.
    Allergy Asthma Proc. 2024;45:14-23.
    PubMed     Abstract available


  14. MAGEN E, Merzon E, Green I, Golan-Cohen A, et al
    A case-control study for comorbidity and laboratory factors associated with food-induced anaphylaxis.
    Allergy Asthma Proc. 2024;45:53-60.
    PubMed     Abstract available


    November 2023
  15. CAN A, Tuzer OC
    The evaluation of melatonin levels in chronic spontaneous urticaria: A case control study.
    Allergy Asthma Proc. 2023;44:e29-e35.
    PubMed     Abstract available


  16. HANANIA NA, Settipane RA, Khoury S, Shaikh A, et al
    Adding tiotropium or long-acting beta2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.
    Allergy Asthma Proc. 2023;44:413-421.
    PubMed     Abstract available


  17. BELLANTI JA, Settipane RA
    Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist.
    Allergy Asthma Proc. 2023;44:379-381.
    PubMed    


  18. NELSON HS
    Allergy immunotherapy for allergic fungal respiratory diseases.
    Allergy Asthma Proc. 2023;44:395-401.
    PubMed     Abstract available


  19. KULUMBEGOV B, Chikovani T, Gotua M, Kikodze N, et al
    Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2023;44:429-435.
    PubMed     Abstract available


  20. KARABAG CITLAK H, Azkur D, Kavas Yildiz Y, Demirel AC, et al
    Cold-induced urticaria in children: A multicenter, retrospective cohort study.
    Allergy Asthma Proc. 2023;44:e36-e43.
    PubMed     Abstract available


  21. KARCHER H, Schoenberger M, Rayban T, Kelly C, et al
    Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.
    Allergy Asthma Proc. 2023;44:422-428.
    PubMed     Abstract available


  22. WALLACE DV
    Evaluation and management of chronic cough in adults.
    Allergy Asthma Proc. 2023;44:382-394.
    PubMed     Abstract available


  23. XU SY, Lv HQ, Zeng CL, Peng YJ, et al
    Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2023;44:402-412.
    PubMed     Abstract available


    September 2023
  24. BRENNAN J, Yamada K, Al-Shaikhly T, Ghaffari G, et al
    Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic.
    Allergy Asthma Proc. 2023;44:333-339.
    PubMed     Abstract available


  25. KHAN NS, Rubin E, McKenna B, Palowitch BL, et al
    The COVID-19 impact on severe uncontrolled asthma costs and biologic use.
    Allergy Asthma Proc. 2023;44:340-344.
    PubMed     Abstract available


  26. ISLAMOGLU C, Arman Bilir O, Ok Bozkaya I, Demirel AC, et al
    Characteristics and management of hypersensitivity reactions with rabbit anti-thymocyte globulin in pediatric patients.
    Allergy Asthma Proc. 2023;44:e22-e28.
    PubMed     Abstract available


  27. BELLANTI JA
    The PANDAS/PANS disorders. Is it time for more allergist-immunologists to get involved?
    Allergy Asthma Proc. 2023;44:296-305.
    PubMed     Abstract available


  28. WANG WT, Li CY, Chang YT, Bai YM, et al
    Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
    Allergy Asthma Proc. 2023;44:345-353.
    PubMed     Abstract available


  29. TURGAY YAGMUR I, Kulhas Celik I, Yilmaz Topal O, Toyran M, et al
    Development of anaphylaxis upon oral food challenge and drug provocation tests in pediatric patients.
    Allergy Asthma Proc. 2023;44:326-332.
    PubMed     Abstract available


  30. BELLANTI JA, Settipane RA
    The challenge of neurologic disease for the allergist/immunologist.
    Allergy Asthma Proc. 2023;44:293-295.
    PubMed    


  31. FENG H, Luo N, Xiong X, Wu Y, et al
    Prevalence of food allergy in the Chinese population: A systematic review and meta-analysis of population-based studies.
    Allergy Asthma Proc. 2023;44:315-325.
    PubMed     Abstract available


  32. NSOULI TM
    New insights in the optimal diagnosis and management of food allergy.
    Allergy Asthma Proc. 2023;44:306-314.
    PubMed     Abstract available


  33. GAJEWSKI AJ, Palka JM, Raitt JM, Agarwal CD, et al
    Association of serotonin reuptake inhibitors with asthma control.
    Allergy Asthma Proc. 2023;44:354-360.
    PubMed     Abstract available


  34. GABRESKI LN, Schuldt MM, Adams KE
    A masquerade of recurrent anaphylaxis.
    Allergy Asthma Proc. 2023;44:374-376.
    PubMed     Abstract available


    July 2023
  35. RIEDL MA, Hinds DR, Prince PM, Alvord TM, et al
    Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
    Allergy Asthma Proc. 2023;44:275-282.
    PubMed     Abstract available


  36. HU H, Hu X, Wang Z, Gao L, et al
    Clinical value of serum soluble receptor for advanced glycation end products in evaluating the condition of patients with bronchial asthma.
    Allergy Asthma Proc. 2023;44:258-264.
    PubMed     Abstract available


  37. TOSCA MA, Ciprandi G
    Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities.
    Allergy Asthma Proc. 2023;44:e2.
    PubMed    


  38. PETERS AT, Wagenmann M, Bernstein JA, Khan AH, et al
    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
    Allergy Asthma Proc. 2023;44:265-274.
    PubMed     Abstract available


  39. BRAKE DR, Yaman RN, Camargo AR, Marks LA, et al
    Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review.
    Allergy Asthma Proc. 2023;44:229-236.
    PubMed     Abstract available


  40. CIHANBEYLERDEN M, Can Bostan O, Tuncay G, Safak C, et al
    Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease.
    Allergy Asthma Proc. 2023;44:e3-e10.
    PubMed     Abstract available


  41. WANG J, Yang Y, Cao J, Song X, et al
    Total serum immunoglobulin E (IgE) as an effective predictor for identifying allergic asthma in childhood asthma.
    Allergy Asthma Proc. 2023;44:252-257.
    PubMed     Abstract available


  42. KUAI S, Zhao P
    Association of EDN levels in patients with asthma and correlation with FEV(1)%: A meta-analysis.
    Allergy Asthma Proc. 2023;44:244-251.
    PubMed     Abstract available


  43. ACQUISTO NM, Bodkin RP, Vabishchevich Y, Falkowski MW, et al
    Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department.
    Allergy Asthma Proc. 2023;44:283-290.
    PubMed     Abstract available


    May 2023
  44. FRENKEL LD, Gaur S, Bellanti JA
    The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Allergy Asthma Proc. 2023 May 26. doi: 10.2500/aap.2023.44.230030.
    PubMed     Abstract available


  45. BELLANTI JA, Settipane RA
    A tribute to allergy and immunology fellowship training program directors and to the fellows they train.
    Allergy Asthma Proc. 2023;44:155-157.
    PubMed    


  46. WITTE J, Singh H, Turk Y, van Huisstede A, et al
    Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up.
    Allergy Asthma Proc. 2023;44:165-170.
    PubMed     Abstract available


  47. CAN A, Coskun R, Karabacak DE, Tuzer OC, et al
    Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance.
    Allergy Asthma Proc. 2023;44:179-185.
    PubMed     Abstract available


  48. DURANT JE, Temple CA, Schachner BI, Zippi Z, et al
    Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022.
    Allergy Asthma Proc. 2023;44:158-164.
    PubMed     Abstract available


  49. CELIK GE, Guloglu Karatas D, Aydin O, Dogu F, et al
    Diagnostic utility of basophil CD203c expression in beta-lactam allergy.
    Allergy Asthma Proc. 2023;44:200-207.
    PubMed     Abstract available


  50. JUNG JH, Park M, Kim GE, Kim JD, et al
    TEV/FEV(3) as a coherent metric of small airway dysfunction in childhood asthma.
    Allergy Asthma Proc. 2023;44:171-178.
    PubMed     Abstract available


  51. SABIT B, Ozdemir O, Kose E
    Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy.
    Allergy Asthma Proc. 2023;44:193-199.
    PubMed     Abstract available


  52. AL S, Asilsoy S, Atay O, Kangalli O, et al
    Transepidermal water loss in allergic diseases.
    Allergy Asthma Proc. 2023;44:186-192.
    PubMed     Abstract available



  53. Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22-23, 2022, Portsmouth, NH.
    Allergy Asthma Proc. 2023;44:213.
    PubMed    



  54. Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    



  55. Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22-23, 2022, Portsmouth, NH.
    Allergy Asthma Proc. 2023;44:213.
    PubMed    



  56. Presented at the Western Society of Allergy, Asthma & Immunology, February 5-9, 2023, Kamuela, Hawaii.
    Allergy Asthma Proc. 2023;44:214-215.
    PubMed    


    March 2023
  57. JHAVERI PB, Lambert KA, Bogale K, Lehman E, et al
    Salivary microRNAs in pediatric eosinophilic esophagitis.
    Allergy Asthma Proc. 2023;44:145-152.
    PubMed     Abstract available


  58. BELLANTI JA, Settipane RA
    The complexities of allergic diseases continue to challenge the allergist-immunologist.
    Allergy Asthma Proc. 2023;44:87-89.
    PubMed    


  59. HU H, Dai J, Zheng X, Wu J, et al
    The relationship of D. pteronyssinus allergic component sIgE and sIgG(4) in house dust mite allergic rhinitis or/and allergic asthma patients.
    Allergy Asthma Proc. 2023;44:100-105.
    PubMed     Abstract available


  60. CHRISTIANSEN SC, Lopes Veronez C, Smith TD, Riedl MA, et al
    Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.
    Allergy Asthma Proc. 2023;44:115-121.
    PubMed     Abstract available


  61. SINGH U, Bernstein JA
    Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
    Allergy Asthma Proc. 2023;44:90-99.
    PubMed     Abstract available


  62. CAN A, Karabacak DE, Yalcin BK, Demir S, et al
    How important is patch testing with dental materials in real-life clinical practice?
    Allergy Asthma Proc. 2023;44:136-144.
    PubMed     Abstract available


  63. CELIK GE, Karakaya G, Erkekol FO, Dursun AB, et al
    Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience.
    Allergy Asthma Proc. 2023;44:106-114.
    PubMed     Abstract available


  64. VITALPUR G, Lahood R, Kussin M, Koenigsberg R, et al
    Impact of penicillin allergy labels among pneumonia admissions at an academic children's center.
    Allergy Asthma Proc. 2023;44:130-135.
    PubMed     Abstract available


  65. MAGEN E, Merzon E, Green I, Magen I, et al
    A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema.
    Allergy Asthma Proc. 2023;44:122-129.
    PubMed     Abstract available


    January 2023
  66. STAMATAKI S, Georgountzou A, Papadopoulos NG, Taka S, et al
    Atopic children are more susceptible to viral respiratory infection at the age of 2-5 years old.
    Allergy Asthma Proc. 2023;44:64-70.
    PubMed     Abstract available


  67. DUFFEY H, Leonard J, Mistry RD
    Variation in diagnosis and management of allergic reactions among emergency medicine and allergy immunology providers.
    Allergy Asthma Proc. 2023;44:51-58.
    PubMed     Abstract available


  68. ZHAO B, Zheng H, Yang T, Zheng R, et al
    Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible.
    Allergy Asthma Proc. 2023;44:59-63.
    PubMed     Abstract available


  69. TRIPATHI SH, Corr A, Kumar A, Ungerer H, et al
    SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.
    Allergy Asthma Proc. 2023;44:78-80.
    PubMed     Abstract available


  70. BELLANTI JA, Settipane RA
    Allergy and immunology: At the crossroad of inflammation and disease.
    Allergy Asthma Proc. 2023;44:1-2.
    PubMed    


  71. BAHNA SL
    The impact of modernization on allergy and asthma development.
    Allergy Asthma Proc. 2023;44:15-23.
    PubMed     Abstract available


  72. ZHANG MS, Huston J, Petrov A, Fajt ML, et al
    Peanut allergy in an adult following cardiac transplant from a non-atopic donor.
    Allergy Asthma Proc. 2023;44:81-84.
    PubMed     Abstract available


  73. KIM H, Alizadehfar R, Alqurashi W, Ellis AK, et al
    Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting.
    Allergy Asthma Proc. 2023;44:45-50.
    PubMed     Abstract available


  74. DO TT, Canty EA, Joshi SR
    Current and future management of chronic spontaneous urticaria and chronic inducible urticaria.
    Allergy Asthma Proc. 2023;44:3-14.
    PubMed     Abstract available


  75. NAVALPAKAM A, Thanaputkaiporn N, Poowuttikul P
    Anaphylaxis: Long-term management and resources.
    Allergy Asthma Proc. 2023;44:35-44.
    PubMed     Abstract available


  76. BRAVO-SOLARTE DC, Garcia-Guaqueta DP, Chiarella SE
    Asthma in pregnancy.
    Allergy Asthma Proc. 2023;44:24-34.
    PubMed     Abstract available


    November 2022
  77. NIEMINEN O, Palosuo K, Kukkonen K, Makela M, et al
    Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children.
    Allergy Asthma Proc. 2022 Nov 18. doi: 10.2500/aap.2023.44.220079.
    PubMed     Abstract available


  78. SALAZAR PE, Habib N, Pasha MA
    2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis.
    Allergy Asthma Proc. 2022;43:529-532.
    PubMed     Abstract available


  79. GULTUNA S
    Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes.
    Allergy Asthma Proc. 2022;43:e65-e71.
    PubMed     Abstract available


  80. ALVES PB, Pereira HP, Alves MP, Roseta L, et al
    Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population.
    Allergy Asthma Proc. 2022;43:533-542.
    PubMed     Abstract available


  81. BELLANTI JA, Settipane RA
    A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
    Allergy Asthma Proc. 2022;43:471-473.
    PubMed    


  82. GRISCTI SOLER D, Bennici A, Brunetto S, Gangemi S, et al
    Benralizumab in the management of rare primary eosinophilic lung diseases.
    Allergy Asthma Proc. 2022;43:494-500.
    PubMed     Abstract available


  83. GROSS LM, Nelson HS, Khatiwada A, Hoyte FCL, et al
    Curcumin does not significantly affect immediate skin tests.
    Allergy Asthma Proc. 2022;43:543-545.
    PubMed     Abstract available


  84. OZTOP N, Demir S, Unal D, Beyaz S, et al
    Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
    Allergy Asthma Proc. 2022;43:519-528.
    PubMed     Abstract available


  85. WALLACE DV
    Treatment options for moderate to severe atopic dermatitis.
    Allergy Asthma Proc. 2022;43:474-493.
    PubMed     Abstract available


  86. FRENKEL LD, Bellanti JA
    Monkeypox viral infection and disease: A challenge for the allergist-immunologist.
    Allergy Asthma Proc. 2022;43:509-518.
    PubMed     Abstract available


  87. NELSON HS
    The return of the mixed respiratory bacterial vaccine.
    Allergy Asthma Proc. 2022;43:501-508.
    PubMed     Abstract available


  88. OZTOP N, Demir S, Toprak ID, Unal D, et al
    Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course.
    Allergy Asthma Proc. 2022;43:546-554.
    PubMed     Abstract available



  89. Abstracts presented at the Eastern Allergy Conference, June 2-5, 2022, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:560-567.
    PubMed    


    September 2022
  90. BOUILLET L, Fain O, Armengol G, Aubineau M, et al
    Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs.
    Allergy Asthma Proc. 2022;43:406-412.
    PubMed     Abstract available


  91. FONACIER L, Banta E, Mawhirt S, Noor I, et al
    Capturing total steroid burden in patients with atopic dermatitis and asthma.
    Allergy Asthma Proc. 2022;43:454-460.
    PubMed     Abstract available


  92. NORRIS M, Ashoor Z, Craig T
    Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus.
    Allergy Asthma Proc. 2022;43:388-396.
    PubMed     Abstract available


  93. KESH S, Singh U, Bernstein JA
    Longitudinal experience with treatment of acquired angioedema using tranexamic acid.
    Allergy Asthma Proc. 2022;43:413-418.
    PubMed     Abstract available


  94. MAMYRBEKOVA S, Iskakova G, Faizullina K, Kuziyeva G, et al
    The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level.
    Allergy Asthma Proc. 2022;43:e58-e64.
    PubMed     Abstract available


  95. BUYUK YAYTOKGIL S, Metbulut AP, Ginis T, Toyran M, et al
    Cat allergy in children and the effect of the COVID-19 pandemic.
    Allergy Asthma Proc. 2022;43:e31-e39.
    PubMed     Abstract available


  96. WANGBERG H, Mortazavi D, Kitsen J, Sanni A, et al
    Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
    Allergy Asthma Proc. 2022;43:446-453.
    PubMed     Abstract available


  97. TAUNK ST, Cardet JC, Ledford DK
    Clinical implications of asthma endotypes and phenotypes.
    Allergy Asthma Proc. 2022;43:375-382.
    PubMed     Abstract available


  98. ZHANG S, Fu Q, Wang S, Jin X, et al
    Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2022;43:e47-e57.
    PubMed     Abstract available


  99. PETERS AT, Bengtson LGS, Chung Y, Emmanuel B, et al
    Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis.
    Allergy Asthma Proc. 2022;43:435-445.
    PubMed     Abstract available


  100. BELLANTI JA
    The long COVID syndrome: A conundrum for the allergist/immunologist.
    Allergy Asthma Proc. 2022;43:368-374.
    PubMed     Abstract available


  101. BELLANTI JA, Settipane RA
    Asthma biomarkers and COVID-19 continue to dominate current medical issues.
    Allergy Asthma Proc. 2022;43:363-367.
    PubMed    


  102. KADDIS T, Joshi S, Anstey KM
    Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
    Allergy Asthma Proc. 2022;43:431-434.
    PubMed     Abstract available


  103. KOIZUMI M, Kuzume K, Ishida Y, Midoro-Horiuti T, et al
    Serum thymus and activation-regulated chemokine (TARC) levels correlate with atopic dermatitis disease severity in patients < 6 months.
    Allergy Asthma Proc. 2022;43:461-467.
    PubMed     Abstract available


  104. RIEDL MA, Neville D, Cloud B, Desai B, et al
    Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives.
    Allergy Asthma Proc. 2022;43:397-405.
    PubMed     Abstract available


    July 2022
  105. CHOI YJ, Seong S, Lee KS, Lee K, et al
    Effects of mechanical washing and drying on the removal of pet allergens.
    Allergy Asthma Proc. 2022 Jul 25. doi: 10.2500/aap.2022.43.220029.
    PubMed     Abstract available


  106. SENGUL EMEKSIZ Z, Yilmaz D, Alan B, Tunc SD, et al
    Clinical utility of serum tryptase levels in pediatric anaphylaxis.
    Allergy Asthma Proc. 2022 Jul 1. doi: 10.2500/aap.2022.43.220042.
    PubMed     Abstract available


  107. PENAGOS M, Durham SR
    Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:292-298.
    PubMed     Abstract available


  108. BELLANTI JA, Settipane RA, DuBuske L
    Essentials of allergen immunotherapy: A primer for the practitioner.
    Allergy Asthma Proc. 2022;43:245-247.
    PubMed     Abstract available


  109. NELSON HS
    Future directions in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:356-362.
    PubMed     Abstract available


  110. GREIWE J, Bernstein JA
    Accelerated/rush allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:344-349.
    PubMed     Abstract available


  111. LARENAS-LINNEMANN D
    Long-term adherence strategies for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:299-304.
    PubMed     Abstract available


  112. WEBER RW
    Assessing cross-reactivity in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:314-321.
    PubMed     Abstract available


  113. TAN TJ, Layhadi JA, Shamji MH
    Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:254-259.
    PubMed     Abstract available


  114. BERNSTEIN DI, Epstein TG
    Safety of subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:267-271.
    PubMed     Abstract available


  115. FINEGOLD I
    A brief history of allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:248-253.
    PubMed     Abstract available


  116. TANKERSLEY M
    Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications.
    Allergy Asthma Proc. 2022;43:322-326.
    PubMed     Abstract available


  117. CALDERON MA, Demoly P
    Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?
    Allergy Asthma Proc. 2022;43:305-309.
    PubMed     Abstract available


  118. GOLDEN DBK
    Venom allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:339-343.
    PubMed     Abstract available


  119. PARASHAR S, Pandya A, Portnoy JM
    Pediatric subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:286-291.
    PubMed     Abstract available


  120. CRETICOS PS
    Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
    Allergy Asthma Proc. 2022;43:260-266.
    PubMed     Abstract available


  121. SUBLETT JL
    United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:333-338.
    PubMed     Abstract available


  122. BLAISS MS
    Pediatric sublingual allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:281-285.
    PubMed     Abstract available


  123. DUBUSKE L
    Efficacy and safety of sublingual allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:272-280.
    PubMed     Abstract available


  124. CAIMMI D, Demoly P
    A review of allergen immunotherapy in asthma.
    Allergy Asthma Proc. 2022;43:310-313.
    PubMed     Abstract available


  125. NELSON HS
    Standardized allergen extracts for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:327-332.
    PubMed     Abstract available


  126. SETTIPANE RA, Bukstein DA
    Allergen immunotherapy and shared decision-making.
    Allergy Asthma Proc. 2022;43:350-355.
    PubMed     Abstract available


    June 2022
  127. KHAN NS, Rubin E, McKenna B, Sonnenberg F, et al
    Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
    Allergy Asthma Proc. 2022 Jun 27. doi: 10.2500/aap.2022.43.220038.
    PubMed     Abstract available


    May 2022
  128. BEYAZ S, Ersoy Y, Bicki E, Ak T, et al
    Psychiatric comorbidity and quality of life in patients with drug hypersensitivity.
    Allergy Asthma Proc. 2022;43:234-242.
    PubMed     Abstract available


  129. BELLANTI JA, Settipane RA
    Eosinophilic esophagitis: from discovery to effective treatment.
    Allergy Asthma Proc. 2022;43:175-177.
    PubMed    


  130. CRAIG T, Feuersenger H, Pragst I, Dang J, et al
    Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
    Allergy Asthma Proc. 2022;43:202-208.
    PubMed     Abstract available


  131. SHER ER, Ross JA, Weine DM, Chandini Arjun A, et al
    Current and emerging therapies for eosinophilic esophagitis.
    Allergy Asthma Proc. 2022;43:178-186.
    PubMed     Abstract available


  132. LANG A, Balmert LC, Weiss M, Pongracic JA, et al
    Real world use of peanut component testing among children in the Chicago metropolitan area.
    Allergy Asthma Proc. 2022;43:226-233.
    PubMed     Abstract available


  133. CAN BOSTAN O, Cakmak ME, Kaya SB, Tuncay G, et al
    The association of timothy grass allergy and cat ownership on cat sensitization.
    Allergy Asthma Proc. 2022;43:220-225.
    PubMed     Abstract available


  134. DENG SJ, Wang J, Liu L, Zhang X, et al
    Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
    Allergy Asthma Proc. 2022;43:209-219.
    PubMed     Abstract available


    March 2022

  135. Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii.
    Allergy Asthma Proc. 2022;43:174.
    PubMed    


  136. DIEHL KC, Popadiuk CA, Agbese E, Leslie DL, et al
    Cost assessment of allergy procedures to improve high-value care implementation.
    Allergy Asthma Proc. 2022;43:168-172.
    PubMed     Abstract available


  137. VOELKER DH, Gonzalez-Estrada A, Park MA
    Female sex as a risk factor for penicillin drug allergy in the inpatient setting.
    Allergy Asthma Proc. 2022;43:163-167.
    PubMed     Abstract available


  138. RAMIREZ RM, Jacobs RL, Andrews CP
    Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.
    Allergy Asthma Proc. 2022;43:116-123.
    PubMed     Abstract available


  139. BELLANTI JA, Settipane RA
    Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
    Allergy Asthma Proc. 2022;43:93-95.
    PubMed    


  140. CHEPY A, Veron M, Gautier S, Farhat MM, et al
    Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.
    Allergy Asthma Proc. 2022;43:155-162.
    PubMed     Abstract available


  141. BEYAZ S, Demir S, Oztop N, Colakoglu B, et al
    How satisfactory is on-demand icatibant from the patients' perspective in real life?
    Allergy Asthma Proc. 2022;43:148-154.
    PubMed     Abstract available


  142. OZDEN SERTCELIK U, Damadoglu E, Karakaya G, Demir AU, et al
    Impact of socioeconomic factors and house cleaning on asthma control in women.
    Allergy Asthma Proc. 2022;43:140-147.
    PubMed     Abstract available


  143. KIM HS, Yang HJ, Song DJ, Lee YJ, et al
    Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
    Allergy Asthma Proc. 2022;43:133-139.
    PubMed     Abstract available


  144. WU G, Hu H, Zhang T, Zhang XD, et al
    Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
    Allergy Asthma Proc. 2022;43:124-132.
    PubMed     Abstract available


    January 2022
  145. MALLIORI S, Ntzounas A, Lampropoulos P, Koliofoti E, et al
    Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991-2018.
    Allergy Asthma Proc. 2022;43:e17-e24.
    PubMed     Abstract available



  146. Abstracts presented at the Eastern Allergy Conference, June 3-6, 2021, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:86-90.
    PubMed    


  147. HARADA K, Baker MG, Agarwal S
    Patient perspectives on penicillin allergy and testing.
    Allergy Asthma Proc. 2022;43:64-69.
    PubMed     Abstract available


  148. BUYUK YAYTOKGIL S, Kulhas Celik I, Karaatmaca B, Ginis T, et al
    Prognosis of food-induced anaphylaxis in children: A single-center real-life study.
    Allergy Asthma Proc. 2022;43:57-63.
    PubMed     Abstract available


  149. SERBES M, Sasihuseyinoglu AS, Ozcan D, Ufuk Altintas D, et al
    Clinical features of anaphylaxis in children.
    Allergy Asthma Proc. 2022;43:50-56.
    PubMed     Abstract available


  150. ALMODALLAL Y, Weaver AL, Joshi AY
    Population-based incidence of food allergies in Olmsted County over 17 years.
    Allergy Asthma Proc. 2022;43:44-49.
    PubMed     Abstract available


  151. AQUINO MR, Bingemann TA, Nanda A, Maples KM, et al
    Delayed allergic skin reactions to vaccines.
    Allergy Asthma Proc. 2022;43:20-29.
    PubMed     Abstract available


  152. YOUSEF E, Korotkaya Y, Simpson AB
    Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup.
    Allergy Asthma Proc. 2022;43:5-11.
    PubMed     Abstract available


  153. GRIVCHEVA-PANOVSKA V, Craig TJ, Longhurst H, Bara N, et al
    Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management.
    Allergy Asthma Proc. 2022;43:e1-e10.
    PubMed     Abstract available


  154. PITLICK MM, Joshi AY, Gonzalez-Estrada A, Chiarella SE, et al
    Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Allergy Asthma Proc. 2022;43:40-43.
    PubMed     Abstract available


  155. GALLAGHER MC, Haessler S, Pecoy-Whitcomb E, Bayuk J, et al
    Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Allergy Asthma Proc. 2022;43:37-39.
    PubMed     Abstract available


  156. MAGEN E, Yakov A, Green I, Israel A, et al
    Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
    Allergy Asthma Proc. 2022;43:30-36.
    PubMed     Abstract available


  157. GANTI P, Suman A, Chaudhary S, Sangha B, et al
    The effect of the socioeconomic status on the measurement of asthma control.
    Allergy Asthma Proc. 2022;43:e11-e16.
    PubMed     Abstract available


  158. MCMURRAY JC, Clair BS, Spriet SW, Min SB, et al
    Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic.
    Allergy Asthma Proc. 2022;43:78-84.
    PubMed     Abstract available


  159. RADOJICIC C
    Guidelines for management of hereditary angioedema: What is new? What is missing?
    Allergy Asthma Proc. 2022;43:12-19.
    PubMed     Abstract available


    November 2021
  160. DEMIRHAN A, Yildirim DD, Arikoglu T, Ozhan AK, et al
    A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children.
    Allergy Asthma Proc. 2021;42:e159-e166.
    PubMed     Abstract available


  161. VEZIR E, Hizal M, Cura Yayla B, Aykac K, et al
    Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
    Allergy Asthma Proc. 2021;42:522-529.
    PubMed     Abstract available


  162. PATEL GB, Chhiba KD, Chen MM, Guo A, et al
    COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Allergy Asthma Proc. 2021;42:515-521.
    PubMed     Abstract available


  163. BURROWS AG, Ellis AK
    Idiopathic anaphylaxis: Diagnosis and management.
    Allergy Asthma Proc. 2021;42:481-488.
    PubMed     Abstract available


  164. VERONEZ CL, Christiansen SC, Smith TD, Riedl MA, et al
    COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
    Allergy Asthma Proc. 2021;42:506-514.
    PubMed     Abstract available


  165. PAN R, Li Q, Zhu X, Zhou Y, et al
    Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.
    Allergy Asthma Proc. 2021;42:e167-e173.
    PubMed     Abstract available


  166. OLGAC M, Guler SD, Demir S, Unal D, et al
    Paucigranulocytic asthma: Do sputum macrophages matter?
    Allergy Asthma Proc. 2021;42:530-536.
    PubMed     Abstract available


  167. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Safety of ciclesonide in children with asthma: A review of randomized controlled trials.
    Allergy Asthma Proc. 2021;42:471-480.
    PubMed     Abstract available


  168. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Review of efficacy of ciclesonide for the treatment of asthma in children.
    Allergy Asthma Proc. 2021;42:461-470.
    PubMed     Abstract available


  169. WALLACE DV
    Treatment options for chronic rhinosinusitis with nasal polyps.
    Allergy Asthma Proc. 2021;42:450-460.
    PubMed     Abstract available


    September 2021
  170. SARIOGLU N, Yalcin AD, Sahin F, Soyyigit S, et al
    Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study.
    Allergy Asthma Proc. 2021;42:e152-e158.
    PubMed     Abstract available


  171. XU H, Gao Y, Xie Y, Liang X, et al
    Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.
    Allergy Asthma Proc. 2021;42:e127-e134.
    PubMed     Abstract available


  172. KOCHIS S, Keet C, Claus LE, Hairston T, et al
    Caregiver perceptions and attitudes associated with oral immunotherapy on social media.
    Allergy Asthma Proc. 2021;42:432-438.
    PubMed     Abstract available


    July 2021
  173. DZIEWA I, Hahn T, Bhardwaj N
    Persistent urticarial rash in a newborn.
    Allergy Asthma Proc. 2021;42:357-361.
    PubMed     Abstract available


  174. MANNING ME, Kashkin JM
    Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
    Allergy Asthma Proc. 2021;42:274-282.
    PubMed     Abstract available


  175. ZHU WJ, Liu Y, Wang G, Deng K, et al
    Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study.
    Allergy Asthma Proc. 2021 Jul 14. doi: 10.2500/aap.2021.42.210052.
    PubMed     Abstract available


  176. OCAK M, Akarsu A, Sahiner UM, Soyer O, et al
    Food protein-induced enterocolitis syndrome: Current practices in oral food challenge.
    Allergy Asthma Proc. 2021;42:343-349.
    PubMed     Abstract available


  177. OCAK M, Nain E, Akarsu A, Sahiner UM, et al
    Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
    Allergy Asthma Proc. 2021;42:325-332.
    PubMed     Abstract available


  178. JOHNSON FA, Wirth M, Zhu Z, Hahn J, et al
    Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment.
    Allergy Asthma Proc. 2021;42:317-324.
    PubMed     Abstract available


  179. KWONG KY, Lu YZ, Jauregui E, Scott L, et al
    Persistent airflow obstruction in inner-city children with asthma.
    Allergy Asthma Proc. 2021;42:310-316.
    PubMed     Abstract available


    May 2021
  180. ALZAABI A, Idrees M, Behbehani N, Salah F, et al
    Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia.
    Allergy Asthma Proc. 2021;42:e77-e85.
    PubMed     Abstract available


  181. VAN ZELST CM, de Boer GM, Turk Y, van Huisstede A, et al
    Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study.
    Allergy Asthma Proc. 2021;42:e71-e76.
    PubMed     Abstract available


  182. AJEWOLE O, Lanlokun M, Dimanche S, Craig T, et al
    Short-term prophylaxis for children and adolescents with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:205-213.
    PubMed     Abstract available


  183. ZHANG S, Bernstein JA
    Mast cell activation syndrome: Myths and realities.
    Allergy Asthma Proc. 2021;42:198-204.
    PubMed     Abstract available


  184. RIEDL MA, Craig TJ, Banerji A, Aggarwal K, et al
    Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
    Allergy Asthma Proc. 2021;42:S17-S25.
    PubMed     Abstract available


  185. CRAIG TJ, Banerji A, Riedl MA, Best JM, et al
    Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.
    Allergy Asthma Proc. 2021;42:S11-S16.
    PubMed     Abstract available


  186. RADOJICIC C, Riedl MA, Craig TJ, Best JM, et al
    Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.
    Allergy Asthma Proc. 2021;42:S4-S10.
    PubMed     Abstract available


  187. BANERJI A, Riedl MA, Craig TJ, Radojicic C, et al
    Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.
    Allergy Asthma Proc. 2021;42:S1-S3.
    PubMed    


    March 2021
  188. WANG Q, Pittman L, Healey A, Chang J, et al
    Ideal body position for epinephrine autoinjector administration.
    Allergy Asthma Proc. 2021;42:147-152.
    PubMed     Abstract available


  189. CASTALDO AJ, Jervelund C, Corcoran D, Boysen HB, et al
    Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:108-117.
    PubMed     Abstract available



  190. For the patient.
    Allergy Asthma Proc. 2021;42:180.
    PubMed    


  191. GENEROSO AJ, Goldman JA, Wolff AH
    A 62-year-old man with new-onset bullae.
    Allergy Asthma Proc. 2021;42:175-179.
    PubMed     Abstract available


  192. BUYUK YAYTOKGIL S, Guvenir H, Kulhas Celik I, Yilmaz Topal O, et al
    Evaluation of drug patch tests in children.
    Allergy Asthma Proc. 2021;42:167-174.
    PubMed     Abstract available


  193. COHEN JS, Agbim C, Hrdy M, Mottla ME, et al
    Epinephrine autoinjector prescription filling after pediatric emergency department discharge.
    Allergy Asthma Proc. 2021;42:142-146.
    PubMed     Abstract available


  194. SWEIS AM, Locke TB, Ig-Izevbekhai KI, Lin TC, et al
    Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2021;42:136-141.
    PubMed     Abstract available


  195. CAO Y, Liu S, Zhi Y
    Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:131-135.
    PubMed     Abstract available


  196. ANAGNOSTOU A
    Weighing the benefits and risks of oral immunotherapy in clinical practice.
    Allergy Asthma Proc. 2021;42:118-123.
    PubMed     Abstract available


  197. BELLANTI JA, Settipane RA
    Hereditary angioedema again revisited.
    Allergy Asthma Proc. 2021;42:105-107.
    PubMed    


    January 2021
  198. YORMAZ B, Menevse E, Cetin N, Esin Celik Z, et al
    Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study.
    Allergy Asthma Proc. 2021;42:e30-e39.
    PubMed     Abstract available


  199. TASHKIN DP, Koltun A, Wallace R
    A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Allergy Asthma Proc. 2021;42:30-35.
    PubMed     Abstract available


  200. JOHNSTON DT, Henry Li H, Craig TJ, Bernstein JA, et al
    Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.
    Allergy Asthma Proc. 2021;42:22-29.
    PubMed     Abstract available


  201. OZDEN MAT D, Firat S, Aksu K, Aksu F, et al
    Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis.
    Allergy Asthma Proc. 2021;42:e25-e29.
    PubMed     Abstract available


  202. MAGEN E, Waitman DA, Kahan NR
    Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2021;42:e17-e24.
    PubMed     Abstract available


  203. TIOTIU A
    Applying personalized medicine to adult severe asthma.
    Allergy Asthma Proc. 2021;42:e8-e16.
    PubMed     Abstract available


  204. SAVARESE L, Mormile I, Bova M, Petraroli A, et al
    Psychology and hereditary angioedema: A systematic review.
    Allergy Asthma Proc. 2021;42:e1-e7.
    PubMed     Abstract available


  205. AYDIN O, Sozener ZC, Demirel YS, Secil D, et al
    Baker's asthma in bread factory workers.
    Allergy Asthma Proc. 2021;42:72-77.
    PubMed     Abstract available


  206. DUDIAK GJ, Popyack J, Grimm C, Tyson S, et al
    Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations.
    Allergy Asthma Proc. 2021;42:65-71.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.